187
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Correlations between circulating levels of adipokines and anti-angiogenic factors in women with BMI <30 and a late-onset preeclampsia

, , , , &

References

  • Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–99
  • Reslan OM, Khalil RA. Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia. Cardiovasc Hematol Agents Med Chem 2010;8:204–26
  • Agarwal I, Karumanchi SA. Preeclampsia and the anti-angiogenic state. Pregnancy Hypertens 2011;1:17–21
  • Cetin I, Hupertz B, Burton G, et al. Pregenesys pre-eclampsia markers consensus meeting: what do we require from markers, risk assessment and model systems to tailor preventive strategies? Placenta 2011;32:S4–16
  • Verlohren S, Stepan H, Dehend R. Angiogenic growth factors in the diagnosis and prediction of pre-clampsia. Clin Sci 2012;122:43–52
  • Maynard SE, Karumanchi SA. Angiogenic factors and preeclampsia. Semin Nephrol 2011;31:33–46
  • Briana DD, Malamitsi-Puchner A. Adipocytokines in normal and complicated pregnancies. Reprod Sci 2009;16:921–37
  • Miehle K, Stepant H, Fasshauer M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and preeclampsia. Clin Endocrinol 2012;76:2–11
  • Vaiopoulos AG, Marinou K, Christodoulides C, Kouutilieris M. The role of adiponectin in human vascular physiology. Int J Cardiol 2012;155:188–93
  • Zhu W, Cheng KKY, Vanhoutte PM, et al. Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci 2008;114:361–74
  • Goldstein BJ, Scalia RG, Ma XL. Protective vascular and myocardial effects of adiponectina. Nat Clin Pract Cardiovasc Med 2009;6:27–35
  • Cao Y. Angiogenesis modulates adipogeneis and obesity. J Clin Investig 2007;117:2362–8
  • Haugen F, Ranheim T, Harsem NK, et al. Incresead plasma levels of adipokinas in preeclampsia: relationship to placent and adipose tissue gene expression. Am J Physiol Endocrinol Metab 2006;290:E326–33
  • Lu D, Yang X, Wu Y, et al. Serum adiponectina, leptin and soluble leptin receptor in pre-eclampsia. Int J Obstet Gynaecol 2006;95:121–6
  • Nakatsukasa H, Masuyama H, Takamoto N, Hiramatsu Y. Circulating leptin and angiogenic factors in preeclampsia patients. Endocr J 2008;55:565–73
  • Suwaki N, Masuyama H, Nakatsukasa H, et al. Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pré-eclampsia. Am J Obstet Gynecol 2006;195:1687–92
  • Masuyama H, Nakatsukasa H, Takamoto N, Hiramatsu Y. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia. J Clin Endocrinol Metab 2007;92:2672–9
  • Anonymous. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1–22
  • Avci I, Zerkan KÖ, Uncu G. Serum adiponectin levels increase in lean preeclamptic women. Prenat Diagn 2010;30:91–2
  • Naruse K, Yamasaki M, Umekage H, et al. Peripheral blood concentrations of adiponectin, an adipocyte-specific plasma protein, in normal pregnancy and preeclampsia. J Reprod Immunol 2005;65:65–75
  • Ramsay JE, Jamieson N, Greer IA, Sattar N. Paradoxical elevation in adiponectin concentrations in women with preeclampsia. J Am Heart Assoc 2003;42:891–4
  • Takemura Y, Osuga Y, Koga K, et al. Selective increase in high molecular weight adiponectina concentration in serum of women with preeclampsia. J Reprod Immunol 2007;73:60–5
  • Dalamaga M, Srinivas SK, Elovitz MA, et al. Serum adiponectin and leptin in relation to risk for preeclampsia: results from a large case-control study. Metabolism 2011;60:1539–44
  • Odden N, Henriksen T, Holter E, et al. Serum adiponectin concentration prior to clinical onset of preeclampsia. Hypertens Pregnancy 2006;25:129–42
  • O’Sullivan AJ, Kriketos AD, Martin A, Brown MA. Serum adiponectin levels in normal and hypertensive pregnancy. Hypertens Pregnancy 2006;25:193–203
  • D’Anna R, Baviera G, Corrado F, et al. Plasma adiponectin concentration in early pregnancy and subsequent risk of hyprtensive disorders. Obstet Gynecol 2005;106:340–4
  • Herse F, Youpeng B, Staff AC, et al. Circulating and uteroplacental adipocitocina concentrations in preeclampsia. Reprod Sci 2009;16:583–90
  • Ouyang Y, Chen H, Chen H. Reduced plasma adiponectin and elevated leptin in pre-eclampsia. Int J Gynecol Obstet 2007;98:110–14
  • Hendler I, Blackwell SC, Mehta SH, et al. The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. Am J Obstet Gynecol 2005;193:979–83
  • Caminos JE, Nogueiras R, Gallego R, et al. Expression and regulation adiponectin and receptor in human and rat placenta. J Clin Endocrinol Metab 2005;90:4276–86
  • Chen J, Tan B, Karteris E, et al. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia 2006;49:1292–302
  • Ichida K, Moriyama T, Morita H, et al. Plasma adiponectin concentrations and placental adiponectin expression in pre-eclamptic women. Gynecol Endocrinol 2007;23:238–43
  • Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. New Engl J Med 2004;350:672–83
  • Ramma W, Buhimschi IA, Zhao G, et al. The elevation in circulating anti-angiogenic factors is independent of markers of neutrophil activation in preeclampsia. Angiogenesis 2012;15:333–40
  • Jeyabalan A, McGonigal S, Gilmourc C, et al. Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia. Placenta 2008;29:555–63
  • Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. New Engl J Med 2006;355:992–1005
  • Adya R, Tan BK, Chen J, Randeva HS. Protective actions of globular and full-length adiponectin on human endothelial cells: novel insights into adiponectin-induced angiogenesis. J Vasc Res 2012;49:534–43
  • Brakenhielm E, Veitonmäki N, Cao R, et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase mediated endothelial cells apoptosis. Natl Acad Sci 2004;101:2476–81
  • Mahadev K, Wu X, Donnelly S, et al. Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells. Cardiovasc Res 2008;78:376–84
  • Ouchi N, Kobayashi H, Kihara S, et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 2004;279:1304–9
  • Shibata R, Ouchi N, Kihara S, et al. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of AMP-activated protein kinase signaling. J Biol Chem 2004;279:28670–4
  • Angnostoulis S, Karyiannakis AJ, Lambropoulou M, et al. Human leptin induces angiogenesis in vivo. Cytokine 2008;42:353–7
  • Basak S, Duttaroy AK. Leptin induces tube formation in first-trimester extravillous trophoblast cells. Eur J Obstet Gynecol Reprod Biol 2012;164:24–9
  • Cao R, Brakenhielm E, Wahlestedt C, et al. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Natl Acad Sci 2001;98:6390–5
  • Pérez-Pérez A, Maymo J, Gambino Y, et al. Leptin stimulates protein synthesis-activating translation machinery in human trophoblastic cells. Biol Reprod 2009;81:826–32

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.